Despite his public criticism of the drug industry’s pricing practices, Gov. Rod Blagojevich has been showering Illinois pharmaceutical companies with tens of millions of dollars in grants and tax breaks to help them expand their operations in Illinois.Blagojevich’s office on Wednesday announced its latest round of incentives: $15 million in tax credits, job training money and other grants to Japan’s largest drugmaker, Takeda Pharmaceutical Co. The company will use the money to assist with an expansion here and relocate from offices in Lincolnshire to a new, larger U.S. headquarters in north suburban Deerfield.It’s the fourth time in the last seven months Blagojevich, through the Illinois Department of Commerce and Economic Opportunity, has awarded certain incentives to drugmakers. In all, nearly $40 million in incentives are being awarded to Takeda; Lake Forest-based drug and device maker Hospira Inc.; Deerfield-based Astellas Pharma U.S. Inc.; and the Illinois Technology Innovation Campus, a proposed redevelopment of the vacant G.D. Searle & Co. drug research facility in Skokie into a biotech center.
